Analyst Ratings for BioXcel Therapeutics (BTAI)

BTAI Rating Summary

BTAI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BTAI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $96.90 (+280.1%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/9/2021 Berenberg Anita Dushyanth New Coverage Buy
(N/A)
75.00
(N/A)
36.02
(25.49)
-29.23% Details
2/1/2021 UBS
» Updated 6/29/2021
Colin Bristow New Coverage Buy
(N/A)
88.00
(92.00)
46.32
(25.49)
-44.97% Details